ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Approves Two Alpha Interferons; Canellos to Give Schwartz Lecture At Scripps Meeting

June 13, 1986

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001